TECH vs BIIB: Which Stock is Better?

Side-by-side comparison of Bio-Techne Corp and Biogen Inc in 2026

Comparison Updated:

TECH

Bio-Techne Corp

$59.00

BIIB

Biogen Inc

$191.82

Key Metrics Comparison

MetricTECHBIIBWinner
Market Cap$9.23B$28.15BBIIB
P/E Ratio111.3221.82BIIB
EPS (TTM)$0.53$8.79BIIB
Revenue Growth-0.0%-0.1%TECH
Gross Margin66.6%78.9%BIIB

Analyze TECH

Full quant analysis

Analyze BIIB

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is TECH or BIIB a better investment?

Comparing TECH and BIIB: Bio-Techne Corp has a market cap of $9.23B while Biogen Inc has $28.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between TECH and BIIB?

TECH (Bio-Techne Corp) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: TECH or BIIB?

Based on P/E ratios, BIIB trades at a lower multiple (21.8x vs 111.3x).

Which is growing faster: TECH or BIIB?

TECH has higher revenue growth at -0.0% vs -0.1% for BIIB.

Which company is more profitable: TECH or BIIB?

Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 66.6% for TECH.

Which is the larger company: TECH or BIIB?

Biogen Inc (BIIB) is larger with a market cap of $28.15B compared to $9.23B for TECH.

Should I buy TECH or BIIB in 2026?

Both TECH and BIIB have investment merit. TECH trades at $59.00 while BIIB trades at $191.82. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between TECH and BIIB stock?

Key differences: Market Cap ($9.23B vs $28.15B), P/E Ratio (111.3x vs 21.8x), Revenue Growth (-0.0% vs -0.1%), Gross Margin (66.6% vs 78.9%).

Popular Stock Comparisons